By Kiran Mazumdar-Shaw, Chairperson, Biocon Group Last week, the PM stated in his Independence Day speech: ‘We are known as the ‘pharmacy of the world’. But isn’t it the need of the hour to invest more in R&D? Shouldn’t we be the ones providing the best and most affordable medicines for the welfare of humanity?’ … Continue reading From pharmacy to innovation hub: Why India needs a regulatory revolution in biotech
India Provides Health Security, Not Just Affordable Drugs, to the World
By Kiran Mazumdar-Shaw, Chairperson, Biocon Group India’s pivotal role in global health security has never been more vital, especially in light of the rising healthcare costs that are putting immense pressure on households, governments, insurers, and healthcare providers worldwide. In 2022, global healthcare spending reached an alarming USD 9.8 trillion, accounting for around 10% of … Continue reading India Provides Health Security, Not Just Affordable Drugs, to the World
A Stable Budget That Could Have Been More Strategic to Enhance Global Competitiveness
By Kiran Mazumdar-Shaw, Chairperson, Biocon Group The Union Budget for FY25-26 is reassuring, as it instils confidence that India is investing in the right areas to drive stable and inclusive economic growth. The eighth consecutive Budget presented by Finance Minister Nirmala Sitharaman is directionally very positive as it addresses key sectors such as healthcare, research … Continue reading A Stable Budget That Could Have Been More Strategic to Enhance Global Competitiveness
Strategic Budget Interventions Can Position Indian Pharma for Global Leadership
By Kiran Mazumdar-Shaw, Chairperson, Biocon Group Pre-budget opinion published in a leading business publication. (Union Budget of India 2025) Finance Minister Nirmala Sitharaman is all set to present the Budget for FY25-26 on February 1, 2025. The upcoming Union Budget presents a unique opportunity to accelerate the growth of India’s pharmaceutical and life sciences sector. … Continue reading Strategic Budget Interventions Can Position Indian Pharma for Global Leadership
Budget Sets a Blueprint for India’s Aspiration of Achieving ‘Developed Nation’ Status
The Union Budget, presented by Finance Minister Nirmala Sitharaman, is a testament to the government’s commitment to realizing India’s dream of developed economy status by 2047. This Budget, an extension of the Interim Budget presented in February 2024, is a pragmatic and balanced financial blueprint that sets the right priorities for the nation’s growth. The … Continue reading Budget Sets a Blueprint for India’s Aspiration of Achieving ‘Developed Nation’ Status
A Budget that Sets the Theme for India’s Future Economic Growth
The Union Budget for FY25 presented by Finance Minister Nirmala Sitharaman builds on the Interim Budget earlier this year and sets the tone for next year's Budget. It aligns with Prime Minister Narendra Modi’s vision of enabling India to achieve a developed economy status by 2047. This statement of intent is clearly supported by a … Continue reading A Budget that Sets the Theme for India’s Future Economic Growth
Finance Minister Unveils a Comprehensive Budget with a Focus on ‘Viksit Bharat’ Vision
Finance Minister Nirmala Sitharaman, in her last Budget before general elections in 2024, has presented an all-encompassing, growth focused financial roadmap that is aligned to India’s aspiration of achieving ‘developed economy’ status by 2047. Growth Oriented Yet Fiscally Prudent The Finance Minister has adeptly struck a balance between fostering economic growth and maintaining fiscal prudence … Continue reading Finance Minister Unveils a Comprehensive Budget with a Focus on ‘Viksit Bharat’ Vision
Budget Needs to Spur Research and Innovation-Led Economic Growth
Finance Minister Nirmala Sitharaman is all set to present the Budget for FY24-25 on February 1, 2024. As the general elections are expected in a few months, this Budget will be an interim one. The economic context in which this Budget will be presented is encouraging. Despite global volatility between 2020 and 2023, India’s GDP grew … Continue reading Budget Needs to Spur Research and Innovation-Led Economic Growth
Year-End Reflection: India’s Biotech and Pharma Sectors Can Catalyse Transformational Growth
As we bid farewell to 2023, it is opportune to reflect on the pivotal juncture that India finds itself in—a moment that holds the promise of transformative growth and innovation in 2024 and beyond. Unleash the Potential of Biotechnology Over the last several years, biotechnology in India has transformed from a nascent sector to a … Continue reading Year-End Reflection: India’s Biotech and Pharma Sectors Can Catalyse Transformational Growth
India Transformed: Modi Government Completes Nine Eventful Years
“It is time for us to realize that we’re too great a nation to limit ourselves to small dreams. We’re not, as some would have us believe, doomed to an inevitable decline. I do not believe in a fate that will fall on us no matter what we do. I do believe in a fate … Continue reading India Transformed: Modi Government Completes Nine Eventful Years